Zhengye Biotechnology Holding
ZYBT
8 hedge funds and large institutions have $68.1K invested in Zhengye Biotechnology Holding in 2026 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.04% less ownership
Funds ownership: 0.26% → 0.21% (-0.04%)
40% less capital invested
Capital invested by funds: $113K → $68.1K (-$44.9K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$4.22K |
| 2 |
JP Morgan Chase
New York
|
+$120 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WG
Winton Group
London,
United Kingdom
|
-$18.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.59K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$39 |
| 4 |
Morgan Stanley
New York
|
-$12 |
ZYBT Hedge Fund Activity: Q2 2026 in Review
8 of the 8,320 institutional investors tracked by Wall St. Rank reported a position in Zhengye Biotechnology Holding (ZYBT) for Q2 2026, worth a combined $68.1K — down 40% from $113K a quarter earlier.
Fund positioning in ZYBT was balanced in Q2 2026: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was XTX Topco, adding an estimated $4.22K. The largest seller was Winton Group, cutting an estimated $18.5K.
- 8 institutional investors held Zhengye Biotechnology Holding (ZYBT) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $68.1K of Zhengye Biotechnology Holding stock for Q2 2026, down 40% quarter-over-quarter.
- 1 fund opened new Zhengye Biotechnology Holding positions in Q2 2026 and 1 closed out, a net change of 0 holders.
- The largest Zhengye Biotechnology Holding buyer in Q2 2026 was XTX Topco, an estimated $4.22K added.
- The largest Zhengye Biotechnology Holding seller in Q2 2026 was Winton Group, an estimated $18.5K sold.
Based on aggregated 13F filings for Q2 2026.